Henning Hölder
Henning Hölder is a financial analyst known for his insights into stock market trends and company evaluations. He has been recognized for his critical assessments of companies' financial performances and market positions, particularly in the context of the dermatology sector. Recently, he provided commentary on Galderma's stock performance, highlighting concerns regarding investor expectations and the company's valuation amidst fluctuating market conditions.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 2 | 5.00 | 0.14% | +10% | 8,654,622 | 13,333 | $700,000 | 1,078$ |
| Totals | 2 | 8,654,622 | 13,333 | $700,000 | 1,078$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Henning Hölder is mentioned in the context of Swiss companies affected by the dollar's weakness.
5
Switzerland:
Henning Hölder is mentioned in the context of the analysis of Barry Callebaut's performance.
5
Switzerland:
Henning Hölder is mentioned as part of the sign-off in the article.
5
Switzerland:
Henning Hölder provides insights on the skepticism surrounding Novartis and its CEO.
5
Switzerland:
Henning Hölder is mentioned as part of the closing remarks in the article.
5
Switzerland:
Henning Hölder is mentioned as having made a relevant comment regarding the stock numbers in the third quarter.
5